1. Home
  2. LSE vs IMUX Comparison

LSE vs IMUX Comparison

Compare LSE & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$4.87

Market Cap

74.4M

Sector

Industrials

ML Signal

N/A

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.19

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSE
IMUX
Founded
2007
2016
Country
China
United States
Employees
N/A
66
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
75.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LSE
IMUX
Price
$4.87
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$4.25
AVG Volume (30 Days)
29.4K
4.7M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$61.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$0.51
52 Week High
$14.99
$1.51

Technical Indicators

Market Signals
Indicator
LSE
IMUX
Relative Strength Index (RSI) 48.99 58.29
Support Level $4.11 $0.64
Resistance Level $5.43 N/A
Average True Range (ATR) 0.58 0.12
MACD -0.03 0.02
Stochastic Oscillator 22.18 51.49

Price Performance

Historical Comparison
LSE
IMUX

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: